e-Science methods reveal new insights into antibiotic resistanceAugust 16, 2005Large-scale computer simulations have pinpointed a tiny change in molecular structure that could account for drug resistance in Streptomices pneumoniae, the organism that causes childhood pneumonia and claims 3.5 million lives a year, mainly in developing countries. Such knowledge could be invaluable in designing new drugs that are effective against the drug resistant strain. Experiments to find out how changes at the molecular level are causing this resistance are difficult and, so far, have not been done. Now, however, Peter Coveney and co-workers from UCL and Queen Mary, University of London have investigated the problem using computer modelling techniques. Their findings are amongst several outputs of the UK e-Science programme that are discussed in a special Theme Issue of Philosophical Transactions of the Royal Society A* which is published on 15 August. They took experimental data gathered from other organisms to build computer models of the sites where drug molecules interact with an organism's protein molecules. They then ran simulations and visualised what happens when a drug molecule approaches each site for both normal and drug-resistant strains of S. pneumoniae.
The simulations and visualisations exploited highly scalable parallel code running on the UK's national supercomputing facilities. "Without the use of e-Science methods, they would have taken months to perform and quite probably would never have been done. With these new methods, each simulation took just 12 hours," says Professor Coveney. So far, life scientists have had limited access to and interest in such high performance computing resources; with Grid computing, these resources are becoming more readily accessible. Professor Coveney and colleagues could see that a very small, but subtle, difference in structure between the normal and drug resistant strains was to blame for the drug resistance. In the normal strain, a drug molecule binds tightly to the site, but in the drug resistant strain it approaches and then drifts slowly away. If the results of the simulation are borne out by experiment, they could point the way to new drugs to combat disease. Engineering and Physical Sciences Research Council | |||||||||||||||||||||
|
Related Drug Resistance Current Events and Drug Resistance News Articles Nature Medicine study shows Peregrine's bavituximab can cure lethal virus infections Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) today reported publication of data in Nature Medicine that supports the broad anti-viral potential of the company's novel anti-phosphatidylserine (anti-PS) antibody platform, showing that its PS-targeting drug bavituximab can cure lethal virus infections in animal disease models. Stopping germs from ganging up on humans Keeping germs from cooperating can delay the evolution of drug resistance more effectively than killing germs one by one with traditional drugs such as antibiotics, according to new research from The University of Arizona in Tucson. Markers of inflammation and blood-clotting tied to hazards of intermittent HIV treatment Episodic treatment of HIV/AIDS with antiretroviral drugs increases the overall risk of death when compared with continuous antiretroviral treatment (ART), but the reasons why have been unknown. Scientists decode genome of parasite that causes relapsing malaria Scientists have deciphered the complete genetic sequence of the parasite Plasmodium vivax, the leading cause of relapsing malaria, and compared it with the genomes of other species of malaria parasites. MU scientists 'see' how HIV matures into an infection After improving the sensitivity of nuclear magnetic resonance (NMR), researchers at the University of Missouri actually watched the HIV-1 protease mature from an inactive form into an active infection. This process has never been directly visualized before. The findings appear today in the journal Nature. HIV drug maraviroc effective for drug-resistant patients As many as one quarter of HIV patients have drug resistance, limiting their treatment options and raising their risk for AIDS and death. Breast cancer treatment resistance linked to signaling pathway Activation of the Src signaling pathway may cause resistance to standard medical treatment in some patients with breast cancer, and inhibition of this pathway holds the potential to overcome that resistance, according to data presented here at the American Association for Cancer Research Molecular Diagnostics in Cancer Therapeutic Development meeting. Best way to treat malaria: Avoid using same drug for everyone, scientists say A team of scientists employing a sophisticated computer model pioneered at Princeton University and Resources for the Future has found that many governments worldwide are recommending the wrong kind of malaria treatment. Study: Delaying evolution of drug resistance in malaria parasite possible There's no magic bullet for wiping out malaria, but a new study offers strong support for a method that effectively delays the evolution of drug resistance in malaria parasites, a University of Florida researcher says. ABC-transporters expressed on endothelial cell membranes efflux anti-HIV drugs Researchers at Tulane University Medical Center in New Orleans (USA) have discovered that drug-efflux pumps, belonging to the ATP-binding cassette (ABC) transporter family, are constitutively expressed on vascular endothelial cells. More Drug Resistance Current Events and Drug Resistance News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||